Skip to content

EASYTRAK® 3 4524Recalls & reported problems

Boston Scientific Corporation · Coronary Venous Steroid-Eluting Bipolar Pace/Sense Lead · Class 3 · Implant

All models of EASYTRAK 3 (3)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
18
Deaths reported
0
Injuries reported
15
Recalls naming it
0

Summary

The FDA's MAUDE database contains 18 adverse event reports that list this exact device (DI 00802526353758), received between Jun 28, 2018 and Dec 30, 2025 — classified as 15 injuries, 3 malfunctions.

The most frequently reported specific device problem is “High Capture Threshold” (3 reports).

19 other recalls cover devices cleared under the same FDA submission (P010012); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 1 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem8
  • High Capture Threshold3
  • Defective Device2
  • Device Dislodged or Dislocated1
  • Difficult to Insert1
  • Failure to Capture1
  • Fracture1
  • Impedance Problem1

Patient problems

  • Unspecified Infection9
  • No Known Impact Or Consequence To Patient5
  • No Code Available4
  • No Clinical Signs, Symptoms or Conditions2
  • Sepsis2
  • Cardiac Arrest1
  • Cardiac Tamponade1
  • Erosion1

Recent adverse event reports

The 18 most recent of 18 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 30, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THIS PREVIOUSLY CAPPED IMPLANTABLE LEAD WAS PART OF THE SYSTEM REVISION DUE TO INFECTION. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THE PREVIOUSLY CAPPED IMPLANTABLE LEAD WAS EXPLANTED.

    Patient problems: Unspecified Infection

    MAUDE report 23931624 ↗
  • MalfunctionOct 28, 2024Over-Sensing; Over-Sensing

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD EXHIBITED OVERSENSING. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THIS LEAD REMAINS IN SERVICE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20547200 ↗
  • InjuryMay 2, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THIS PREVIOUSLY CAPPED LEFT VENTRICULAR (LV) LEAD WAS PART OF SYSTEM REVISION DUE TO INFECTION. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. THE PREVIOUSLY CAPPED LV LEAD REMAINS SURGICALLY ABANDONED.

    Patient problems: Unspecified Infection

    MAUDE report 19235553 ↗
  • MalfunctionOct 3, 2023Difficult to Insert; Difficult to Insert

    IT WAS REPORTED THAT THERE WERE DIFFICULTIES GETTING THIS LEFT VENTRICULAR (LV) LEAD INTO THE HEADER OF THE CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D). TECHNICAL SERVICES (TS) PROVIDED A RESOLUTION OPTION. NO ADVERSE PATIENT EFFECTS WERE REPORTED. ADDITIONAL INFORMATION INDICATES THAT THIS LEAD ABLE TO BE CONNECTED TO THE HEADER OF THE DEVICE AFTER PUSHING THE LEAD IN HARDER. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17859780 ↗
  • InjuryOct 25, 2022Fracture; Fracture

    IT WAS REPORTED THAT THE PATIENT WITH THIS RIGHT ATRIAL (RA) LEAD EXHIBITED INFECTION. REPORTEDLY, WHILE PERFORMING RIGHT VENTRICULAR (RV) LEAD EXTRACTION, THE LEFT VENTRICULAR (LV) LEAD WAS FRACTURED AND THE COIL UNRAVELED; HENCE, THE LV LEAD WAS ABANDONED FOR THE TIME BEING. MOREOVER, WHILE PULLING OUT THE RIGHT ATRIAL (RA) LEAD, THE ANESTHESIOLOGIST NOTICED AN EFFUSION IN THE RIGHT ATRIUM AND THE PATIENT EXPERIENCED CARDIAC ARREST. CARDIOPULMONARY RESUSCITATION (CPR) WAS PERFORMED. SUBSEQUENTLY, AN OPEN-HEART PROCEDURE WAS DONE TO FIX THE EFFUSION. A REVISION WAS PERFORMED AND THE CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) ALONG WITH THE RIGHT VENTRICULAR (RV) LEAD AND RIGHT ATRIAL (RA), AND LEFT VENTRICULAR (LV) LEADS WERE EXPLANTED. THERE WERE NO ADVERSE PATIENT EFFECTS REPORTED. THE LV LEAD WILL NOT BE RETURNED.

    Patient problems: Cardiac Arrest; Cardiac Tamponade; Pericardial Effusion; Unspecified Infection

    MAUDE report 15671040 ↗
  • InjuryNov 3, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS ERODED AFTER THE PATIENT BUMPED THE DEVICE WHICH DEVELOPED A HEMATOMA THEREFORE THE WHOLE SYSTEM HAD INFECTION WITH SEPSIS. A REVISION WAS PERFORMED AND THE LV LEAD WAS EXPLANTED. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED.

    Patient problems: Hematoma; Pocket Erosion; Sepsis; Unspecified Infection

    MAUDE report 12741955 ↗
  • InjuryOct 7, 2020Failure to Capture; Failure to Capture

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR LEAD WAS EXHIBITING NO CAPTURE. THE LEAD WAS SURGICALLY ABANDONED AND REPLACED DURING AN ELECTIVE DEVICE REPLACEMENT PROCEDURE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Code Available

    MAUDE report 10642707 ↗
  • InjuryJul 22, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS PART OF A SYSTEM REVISION DUE TO INFECTION. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THE LV LEAD WAS EXPLANTED.

    Patient problems: No Code Available; Unspecified Infection

    MAUDE report 10311553 ↗
  • InjuryJul 1, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS PART OF A SYSTEM REVISION DUE TO INFECTION WITH SEPSIS. THE PATIENT WAS TREATED WITH INTRAVENOUS ANTIBIOTICS. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THIS PREVIOUSLY CAPPED LEAD WAS NOW EXPLANTED.

    Patient problems: Sepsis; Unspecified Infection

    MAUDE report 10221620 ↗
  • InjuryJan 14, 2020High Capture Threshold; High Capture Threshold

    IT WAS REPORTED THAT ELEVATED THRESHOLD MEASUREMENTS WERE NOTED WITH THIS LEFT VENTRICULAR (LV) LEAD. A BOSTON SCIENTIFIC TECHNICAL SERVICES CONSULTANT DISCUSSED THE CLINICAL OBSERVATIONS WITH THE CALLER. A REVISION PROCEDURE WAS PERFORMED TO REPLACE THIS LEAD; HOWEVER, SUCCESSFUL PLACEMENT OF A REPLACEMENT LEAD WAS UNSUCCESSFUL. THE SYSTEM REMAINS IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 9588121 ↗
  • InjuryJan 6, 2020Defective Device; Defective Device

    IT WAS REPORTED THAT THIS LEAD WAS SURGICALLY ABANDONED DUE TO HIGH PACING THRESHOLDS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Code Available; No Known Impact Or Consequence To Patient

    MAUDE report 9550824 ↗
  • InjuryJan 3, 2020Defective Device; Impedance Problem; Material Integrity Problem; Defective Device; Impedance Problem; Material Integrity Problem

    IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS EXPLANTED DUE TO IMPEDANCE ISSUES THAT APPEAR TO BE CAUSED BY A LEAD FRACTURE. THIS LEAD WAS SUCCESSFULLY REPLACED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Code Available; No Known Impact Or Consequence To Patient

    MAUDE report 9548942 ↗
  • MalfunctionMay 6, 2019Low impedance; Low impedance

    IT WAS REPORTED THAT PACING LEAD IMPEDANCE MEASUREMENTS ON THIS LEFT VENTRICULAR (LV) LEAD, WHICH WERE 500 OHMS AT IMPLANT AND WERE CURRENTLY APPROXIMATELY 300 OHMS, HAD DROPPED BELOW 200 OHMS ONE TIME. THIS MEASUREMENT WAS NOT REPRODUCIBLE. THRESHOLDS AND SENSING MEASUREMENTS WERE WITHIN NORMAL LIMITS AND NO NOISE WAS PRESENT. A BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) RECOMMENDED MONITORING. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THIS LEAD REMAINS IN SERVICE.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 8584567 ↗
  • InjuryMay 6, 2019Device Dislodged or Dislocated; High Capture Threshold; Device Dislodged or Dislocated; High Capture Threshold

    BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT'S LEFT VENTRICULAR (LV) LEAD EXHIBITED HIGH PACING THRESHOLDS. THIS LV LEAD WAS ABANDONED SURGICALLY. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 8583987 ↗
  • InjuryApr 17, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS PRODUCT WAS PART OF A SYSTEM REVISION DUE TO INFECTION. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THE PRODUCT WAS EXPLANTED.

    Patient problems: Unspecified Infection

    MAUDE report 8524148 ↗
  • InjuryJan 28, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THIS PATIENT HAD AN INFECTION AND EROSION OF THEIR DEVICE SYSTEM. THIS WAS A LIFE-THREATENING SITUATION AND THE PATIENT WAS TREATED. THIS LEAD IS CURRENTLY STILL IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Erosion; Unspecified Infection

    MAUDE report 8283297 ↗
  • InjuryOct 24, 2018High Capture Threshold; High Capture Threshold

    BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS LEFT VENTRICULAR (LV) LEAD WAS SURGICALLY ABANDONED DUE TO HIGH PACING THRESHOLDS. ADDITIONAL INFORMATION INDICATED THAT THE CAUSE FOR HIGH THRESHOLD WAS UNCONFIRMED AS LEAD INSULATION LOOKED NORMAL AND X-RAY DID NOT SHOW ANY ABNORMALITIES. THIS LV LEAD IS NO LONGER IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 8000188 ↗
  • InjuryJun 28, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS LEFT VENTRICULAR (LV) LEAD HAD AN INFECTION AND A SYSTEM EXTRACTION WAS PLANNED. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THE LV LEAD REMAINS IN SERVICE.

    Patient problems: Unspecified Infection

    MAUDE report 7648377 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P010012. One submission often covers many models, so check the product and lot details in each record.

  • Z-1671-2022 · Jul 7, 2022 · Open, Classified
    The PRM is intended to be used as part of the ZOOM LATITUDE Programming System to communicate with Boston Scientific implantable pulse generators. The software in use controls all
  • Z-0081-2018 · Oct 4, 2017 · Terminated
    RESONATE X4 CRT-D, Model G447, Sterile.
  • Z-0079-2018 · Oct 4, 2017 · Terminated
    VIGILANT X4 CRT-D, Model G247, Sterile. Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) are indicated for patients with heart failure who receive stable optimal pharma
  • Z-0080-2018 · Oct 4, 2017 · Terminated
    MOMENTUM X4 CRT-D, Model G138, Sterile.
  • Z-1556-2010 · Mar 15, 2010 · Terminated
    Boston Scientific LIVIAN Cardiac Resynchronization Therapy Defibrillator (CRT-D), models H220, H225, H227, H229. The LIVIAN family of cardiac resynchronization therapy defibrillat
  • Z-0609-2010 · Dec 1, 2009 · Terminated
    Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. the following models are not available in the US: models N106, N107, P106, P107,
  • Z-1053-2007 · Mar 23, 2007 · Terminated
    VITALITY 2 (model T165, T175), VITALITY DS (model T125, T135), VITALITY EL (model T127), Implantable Cardioverter Defibrillators (ICD), are designed to detect and terminate ventric
  • Z-1047-2007 · Mar 23, 2007 · Terminated
    CONTAK RENEWAL 3 (model H170, H175) CONTAK RENEWAL 3 HE (model H177, H179) Cardiac Resynchronization Therapy Defibrillator (CRT-D). Guidant Corporation, 4100 Hamline Avenue North,
  • Z-1052-2007 · Mar 23, 2007 · Terminated
    VITALITY AVT (model A155). Implantable Cardioverter Defibrillator. Atrial and Ventricular Therapies. Guidant Corporation Cardiac Rhythm Management, 4100 Hamline Avenue North, St. P
  • Z-1049-2007 · Mar 23, 2007 · Terminated
    CONTAK RENEWAL 3 RF (model H210, H215), CONTAK RENEWAL 3 RF HE (model H217, H219) cardiac resynchronization therapy defibrillator (CRT-D).
  • Z-1054-2007 · Mar 23, 2007 · Terminated
    VITALITY DR HE Implantable Cardioverter Defibrillator (model T180). Sterile EO. Guidant Corporation, Cardiac Rhythm Management, 4100 Hamline Avenue North, St. Paul, MN 55112-5798 U
  • Z-1055-2007 · Mar 23, 2007 · Terminated
    VITALITY 2 EL DR/VR (model T167, T177). contents have been sterilized with gaseous ethylene oxide. The Guidant Vitality 2 ICD, implantable cardioverter defibrillators, are design
  • Z-0047-2008 · Mar 16, 2007 · Terminated
    Guidant VITALITY VR/DR, Implantable Cardioverter Defibrillator, ICD, Models 1870 and 1871. Guidant VITALITY DR+, Implantable Cardioverter Defibrillator, ICD, Model 1872.
  • Z-1288-06 · May 15, 2006 · Terminated
    Guidant CONTAK RENEWAL 3 (models H170, H175) CONTAK RENEWAL 3 HE (models H177, H179) Cardiac Resynchronization Therapy Defibrillator (CRT-D). Guidant Corporation, 4100 Hamline Ave
  • Z-0825-06 · Apr 7, 2006 · Terminated
    Guidant CONTAK RENEWAL 3 (models H170,H175) CONTAK RENEWAL 3 HE (models H177, H179) Cardiac Resynchronization Therapy Defibrillator (CRT-D). Sterile EO. Guidant Corporation, 4100

…and 4 more.

Other Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D) devices

All Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page